Videos

Did you know that colon cancer is the third most deadly cancer worldwide? Unfortunately, while immunotherapy is quite effective in the treatment of many cancers, such as skin cancer, it only works in 5% of colon cancer patients. Sara Verbandt (KU Leuven) explains how she wants to make immunotherapy stand up against colon cancer.

Immunotherapy is a very promising therapy for cancer, but only 15 to 30% of the patients respond to this kind of therapy. Giving immunotherapy to patients without knowing whether they will respond is expensive and can even harm them. That's why Madhavi Andhari is looking for markers to tell apart responders from non-responders.

As if developing a cancer drug is not difficult enough, you still have to successfully get that medicine to the tumor. Tim Bomberna (Ghent University) explains how computer simulations show us the way.

Imagine having to visit the toilet 30 times a day for 'number two'. That's not possible, right? Unfortunately, it's the reality for a lot of patients with rectal cancer who've had rectal surgery. Anne Asnong tries to help these people so that they no longer have to spend their life 'chained' to the toilet seat. 🚽

Quitting smoking is quite a challenge. In her PhD, Karolien Adriaens (KU Leuven) shows that the e-cigarette is an effective tool to help smokers eventually get rid of their addiction.

Chemotherapy affects the brains of patients. It can lead to cognitive complaints, stress, and fatigue. Michelle Melis achieves promising results with mindfulness in patients with breast cancer. 

What is the link between a smoothie and the analysis of cancer tumours? Well, Sebastiaan Vanuytven explains it smooth(l)y in this video

Melanoma is a very common and lethal type of skin cancer. Melanoma cells have a strange, yet effective defence mechanism called autophagy: they can manage to survive by eating parts of themselves. Monica Vara Perez tries to figure out this self-cannibalism mechanism in order to help defeat melanoma.

Many types of cancer are still being diagnosed too late. The disease has then often already spread, making it difficult to treat the patients. Can we improve early diagnostics in cancer? The answer is hidden in the proteins of the cell, as Guillermo Solis Fernandez explains. 

Immunotherapy is increasingly being used in the fight against cancer. But this therapy does not work for all patients. You would think that if it doesn't work, it doesn't it hurt. Unfortunately, it does! Marlies Vanden Bempt (VIB - KU Leuven) explains why.

Despite recent advances in breast cancer treatment, too many women still die once this cancer has spread throughout their body. That's why Matteo Rossi is looking to find weaknesses of breast cancer cells, in order to defeat them.

Waiting for results after a medical examination often causes stress and uncertainty, especially in cancer patients. That is why Elien De Thaye is working on a method to determine the effect of a chemo treatment on people with peritoneal cancer more quickly on the basis of a so-called marker in the blood.